Packaged Foods
Compare Stocks
4 / 10Stock Comparison
HCWC vs WELL vs VTR vs XWEL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
Personal Products & Services
HCWC vs WELL vs VTR vs XWEL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Packaged Foods | REIT - Healthcare Facilities | REIT - Healthcare Facilities | Personal Products & Services |
| Market Cap | $4M | $149.25B | $41.15B | $7M |
| Revenue (TTM) | $78M | $11.63B | $6.13B | $29M |
| Net Income (TTM) | $-4M | $1.43B | $260M | $-17M |
| Gross Margin | 39.6% | 39.1% | -4.3% | 22.7% |
| Operating Margin | -1.5% | 4.4% | 13.4% | -32.0% |
| Forward P/E | — | 78.4x | 118.0x | — |
| Total Debt | $26M | $21.38B | $13.22B | $12M |
| Cash & Equiv. | $2M | $5.03B | $741M | $3M |
HCWC vs WELL vs VTR vs XWEL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 24 | May 26 | Return |
|---|---|---|---|
| Healthy Choice Well… (HCWC) | 100 | 11.4 | -88.6% |
| Welltower Inc. (WELL) | 100 | 166.4 | +66.4% |
| Ventas, Inc. (VTR) | 100 | 134.9 | +34.9% |
| XWELL, Inc. (XWEL) | 100 | 73.4 | -26.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCWC vs WELL vs VTR vs XWEL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCWC is the clearest fit if your priority is growth exposure.
- Rev growth 24.6%, EPS growth 55.6%, 3Y rev CAGR 83.5%
WELL carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs VTR's 65.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs XWEL's -13.8%
- Better valuation composite
VTR is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs HCWC's 1.66, lower leverage
XWEL is the clearest fit if your priority is momentum.
- +54.5% vs HCWC's -24.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs XWEL's -13.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.3% margin vs XWEL's -58.2% | |
| Stability / Safety | Beta 0.01 vs HCWC's 1.66, lower leverage | |
| Dividends | 1.3% yield, 2-year raise streak, vs XWEL's 3.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +54.5% vs HCWC's -24.8% | |
| Efficiency (ROA) | 2.3% ROA vs XWEL's -84.7%, ROIC 0.5% vs -124.8% |
HCWC vs WELL vs VTR vs XWEL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HCWC vs WELL vs VTR vs XWEL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
WELL leads in 2 of 6 categories
HCWC leads 1 • VTR leads 1 • XWEL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — HCWC and WELL and VTR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 398.2x XWEL's $29M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to XWEL's -58.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $78M | $11.6B | $6.1B | $29M |
| EBITDAEarnings before interest/tax | $2M | $2.8B | $2.3B | -$8M |
| Net IncomeAfter-tax profit | -$4M | $1.4B | $260M | -$17M |
| Free Cash FlowCash after capex | $2M | $2.5B | $1.4B | -$12M |
| Gross MarginGross profit ÷ Revenue | +39.6% | +39.1% | -4.3% | +22.7% |
| Operating MarginEBIT ÷ Revenue | -1.5% | +4.4% | +13.4% | -32.0% |
| Net MarginNet income ÷ Revenue | -5.4% | +12.3% | +4.2% | -58.2% |
| FCF MarginFCF ÷ Revenue | +2.2% | +21.9% | +22.4% | -40.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +29.5% | +40.3% | +22.0% | -4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.0% | +22.5% | 0.0% | -105.0% |
Valuation Metrics
HCWC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 153.3x trailing earnings, WELL trades at a 4% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, VTR's 24.3x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $4M | $149.2B | $41.1B | $7M |
| Enterprise ValueMkt cap + debt − cash | $27M | $165.6B | $53.6B | $17M |
| Trailing P/EPrice ÷ TTM EPS | -0.59x | 153.25x | 160.26x | -0.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x | 118.01x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.40x | 24.31x | — |
| Price / SalesMarket cap ÷ Revenue | 0.05x | 13.99x | 7.05x | 0.24x |
| Price / BookPrice ÷ Book value/share | 1.13x | 3.35x | 3.18x | — |
| Price / FCFMarket cap ÷ FCF | — | 52.41x | 31.25x | — |
Profitability & Efficiency
WELL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-74 for HCWC. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to HCWC's 10.72x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs XWEL's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -73.9% | +3.5% | +2.1% | — |
| ROA (TTM)Return on assets | -11.7% | +2.3% | +1.0% | -84.7% |
| ROICReturn on invested capital | -5.6% | +0.5% | +2.5% | -124.8% |
| ROCEReturn on capital employed | -8.5% | +0.6% | +3.2% | -129.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 2 |
| Debt / EquityFinancial leverage | 10.72x | 0.49x | 1.05x | — |
| Net DebtTotal debt minus cash | $23M | $16.3B | $12.5B | $10M |
| Cash & Equiv.Liquid assets | $2M | $5.0B | $741M | $3M |
| Total DebtShort + long-term debt | $26M | $21.4B | $13.2B | $12M |
| Interest CoverageEBIT ÷ Interest expense | -1.15x | 0.26x | 1.40x | -128.64x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $504 for XWEL. Over the past 12 months, XWEL leads with a +54.5% total return vs HCWC's -24.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs HCWC's -62.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.5% | +14.3% | +12.6% | +182.2% |
| 1-Year ReturnPast 12 months | -24.8% | +42.7% | +33.9% | +54.5% |
| 3-Year ReturnCumulative with dividends | -94.6% | +189.5% | +94.2% | -75.6% |
| 5-Year ReturnCumulative with dividends | -94.6% | +202.3% | +74.8% | -95.0% |
| 10-Year ReturnCumulative with dividends | -94.6% | +223.1% | +65.0% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -62.1% | +42.5% | +24.8% | -37.5% |
Risk & Volatility
VTR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than HCWC's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs HCWC's 29.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.66x | 0.13x | 0.01x | 0.88x |
| 52-Week HighHighest price in past year | $0.98 | $219.59 | $88.50 | $2.20 |
| 52-Week LowLowest price in past year | $0.22 | $142.65 | $61.76 | $0.26 |
| % of 52W HighCurrent price vs 52-week peak | +29.1% | +97.0% | +97.8% | +57.7% |
| RSI (14)Momentum oscillator 0–100 | 56.8 | 60.2 | 56.2 | 53.4 |
| Avg Volume (50D)Average daily shares traded | 500K | 2.6M | 3.4M | 2.3M |
Analyst Outlook
Evenly matched — WELL and XWEL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", VTR as "Buy". Consensus price targets imply 6.3% upside for WELL (target: $227) vs 4.9% for VTR (target: $91). For income investors, XWEL offers the higher dividend yield at 3.78% vs WELL's 1.30%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — |
| Price TargetConsensus 12-month target | — | $226.50 | $90.80 | — |
| # AnalystsCovering analysts | — | 34 | 32 | — |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +2.1% | +3.8% |
| Dividend StreakConsecutive years of raises | — | 2 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | $2.76 | $1.86 | $0.05 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +25.4% |
WELL leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). HCWC leads in 1 (Valuation Metrics). 2 tied.
HCWC vs WELL vs VTR vs XWEL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HCWC or WELL or VTR or XWEL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -13. 8% for XWELL, Inc. (XWEL). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCWC or WELL or VTR or XWEL?
On trailing P/E, Welltower Inc.
(WELL) is the cheapest at 153. 3x versus Ventas, Inc. at 160. 3x. On forward P/E, Welltower Inc. is actually cheaper at 78. 4x.
03Which is the better long-term investment — HCWC or WELL or VTR or XWEL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -95. 0% for XWELL, Inc. (XWEL). Over 10 years, the gap is even starker: WELL returned +223. 1% versus XWEL's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCWC or WELL or VTR or XWEL?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus Healthy Choice Wellness Corp. 's 1. 66β — meaning HCWC is approximately 17358% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 11% for Healthy Choice Wellness Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — HCWC or WELL or VTR or XWEL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -13. 8% for XWELL, Inc. (XWEL). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -38. 8% for XWELL, Inc.. Over a 3-year CAGR, HCWC leads at 83. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCWC or WELL or VTR or XWEL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -58. 2% for XWELL, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTR leads at 14. 2% versus -32. 0% for XWEL. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCWC or WELL or VTR or XWEL more undervalued right now?
On forward earnings alone, Welltower Inc.
(WELL) trades at 78. 4x forward P/E versus 118. 0x for Ventas, Inc. — 39. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 6. 3% to $226. 50.
08Which pays a better dividend — HCWC or WELL or VTR or XWEL?
In this comparison, XWEL (3.
8% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. HCWC does not pay a meaningful dividend and should not be held primarily for income.
09Is HCWC or WELL or VTR or XWEL better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Healthy Choice Wellness Corp. (HCWC) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VTR: +65. 0%, HCWC: -94. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCWC and WELL and VTR and XWEL?
These companies operate in different sectors (HCWC (Consumer Defensive) and WELL (Real Estate) and VTR (Real Estate) and XWEL (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCWC is a small-cap high-growth stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; XWEL is a small-cap income-oriented stock. WELL, VTR, XWEL pay a dividend while HCWC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.